See Bristol-Myers Squibb's analyst price targets ($68) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$63.64
7 analysts in the last 4 months
High: $75 | Low: $59
No recommendations in the last 4 months.
As of the most recent data, BMY shows a target price of $68. Scroll down for historical charts and peer comparison views.
If Bristol-Myers Squibb moved to the average analyst target of $68, shares would be roughly 7.3% higher than $63.64. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Bristol-Myers Squibb's earnings trajectory.
Besides this target price page, Stockcircle has Bristol-Myers Squibb's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $68) with ownership activity and broader fundamentals.
Bristol-Myers Squibb's target price is $68; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.